{"id":17369,"date":"2017-10-03T17:50:11","date_gmt":"2017-10-03T13:50:11","guid":{"rendered":"http:\/\/www.intelligentcio.com\/eu\/?p=17369"},"modified":"2017-10-03T17:50:11","modified_gmt":"2017-10-03T13:50:11","slug":"turacoz-healthcare-solutions-picks-acceliant-to-strengthen-clinical-trial-offerings","status":"publish","type":"post","link":"https:\/\/www.intelligentcio.com\/eu\/2017\/10\/03\/turacoz-healthcare-solutions-picks-acceliant-to-strengthen-clinical-trial-offerings\/","title":{"rendered":"Turacoz Healthcare Solutions picks Acceliant to strengthen clinical trial offerings"},"content":{"rendered":"<p>Acceliant, the global leader in e-clinical data management solutions, has partnered with Turacoz, a leading medical communications company that provides customised, cost-effective solutions to the healthcare and pharmaceutical industries.<\/p>\n<p>Turacoz will leverage its association with Acceliant to strengthen its technological capabilities in PMS, registry, observational and real-world evidence studies globally. The expanded use of Acceliant will also help Turacoz to extend a seamless product experience to its clients. Meanwhile, Acceliant now has a complete spectrum of end-to-end solutions and services (ranging from medical writing, clinical operations, data management, pharmacovigilance and publications) for late phase studies through this alliance.<\/p>\n<p>&#8220;Our partnership with Acceliant will help us enable a unique complete solution offering for our clients. We expect to address some of the major industry challenges, such as operational efficiency and data integrity, with this collaboration,&#8221; Dr. Namrata Singh, Founder and Director of Turacoz, said in a statement. &#8220;We will work closely with Acceliant and establish a complete service spectrum for real-world evidence solutions and observational studies,&#8221; she added.  <\/p>\n<p>Prashant Bhavaraju, Chief Marketing Officer of Acceliant, said, &#8220;Acceliant is really delighted to expand its partnership with Turacoz. Our e-clinical suite for pharma and medical devices companies, and CROs is a battle-tested platform; also one of the most highly advanced and smart EDC products in the market today. With this partnership, we will be able to give a one-stop experience to our clients.&#8221;    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Acceliant, the global leader in e-clinical data management solutions, has partnered with Turacoz, a leading medical communications company that provides customised, cost-effective solutions to the healthcare and pharmaceutical industries. Turacoz will leverage its association with Acceliant to strengthen its technological capabilities in PMS, registry, observational and real-world evidence studies globally. The expanded use of Acceliant [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":17370,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[86,14],"tags":[2593,2594,2595,2596,2597,2598,2599,2600,2601,2602],"class_list":["post-17369","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","category-more-news","tag-acceliant","tag-data-integrity","tag-e-clinical","tag-e-clinical-data-management-solutions","tag-edc-products","tag-end-to-end-solutions","tag-leading-medical-communications-company","tag-operational-efficiency","tag-technological-capabilities","tag-turacoz"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/posts\/17369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/comments?post=17369"}],"version-history":[{"count":0,"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/posts\/17369\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/media\/17370"}],"wp:attachment":[{"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/media?parent=17369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/categories?post=17369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.intelligentcio.com\/eu\/wp-json\/wp\/v2\/tags?post=17369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}